Get 10% off For taking quiz
FREE SHIPPING & RETURNS
on all orders over $75.
MONEY BACK GUARANTEE
100% money back guarantee.
Support 24/7
customersuccess@countrywidetesting.com

72-Hour Split Specimen Drug Test Rights for U.S. Employers & Employees

by Stephanie

A split specimen drug test divides a donor’s original urine sample into a primary bottle (Bottle A) and a split bottle (Bottle B). After a verified positive, adulterated, or substituted result, the donor has 72 hours from MRO notification to request that Bottle B be sent to a second HHS-certified lab for reconfirmation. The employer must ensure that testing proceeds. Split testing confirms the original result; it is never a chance to submit a new sample.

TL;DR:

  • Only a donor may ask the MRO to test Bottle B, and a timestamped written message helps protect against disputes over the deadline.
  • The employer must arrange forwarding promptly even if the employee cannot pay upfront; cost recovery may follow company policy or a labor agreement.
  • If no qualified lab can test a specific adulterant, the MRO cancels the test and directs an immediate new collection under direct observation.
  • A failed reconfirmation cancels the original test rather than making it negative; inconsistent findings may prompt validity testing or a third HHS certified lab review.
  • An invalid primary result does not qualify for split testing; federal procedures instead call for a new collection, unlike positive, adulterated, or substituted findings.
Countrywidetesting
Support Compliant Drug Testing
Explore drug testing products and laboratory services for employers and organizations managing workplace screening needs.
Explore testing services

Table of Contents

What a split specimen test is and why federal rules require it

A split specimen collection divides a single void into two sealed containers at the time of collection, so that one bottle can later verify the other without needing the donor to return. Federal agencies, including those regulated under the Department of Transportation, rely on this model for safety-sensitive drug testing programs covering truck drivers, pilots, rail workers, and others in similarly regulated roles.

The authority for the entire process sits in 49 CFR Part 40, the DOT regulation governing workplace drug and alcohol testing procedures, alongside the HHS Mandatory Guidelines that set lab and collection standards. These two frameworks work together: Part 40 tells employers and Medical Review Officers what to do, while HHS guidance tells collectors and laboratories how to do it.

Split testing exists for a narrow purpose. It applies only when:

  • Bottle A returns a confirmed positive, adulterated, or substituted result.
  • The donor submits a timely, valid request to test Bottle B.
  • The result being challenged is not classified as “invalid,” since invalid results have no split-testing option and instead require a new collection.

How the collection actually happens, step by step

The split specimen process starts the moment the donor arrives at the collection site, and every step gets logged on the Federal Custody and Control Form (CCF), the document that tracks the specimen from collection to lab result.

  1. The collector unwraps both specimen bottles in the donor’s presence, confirming they are unused and intact, following the SAMHSA Urine Specimen Collection Handbook.
  2. The donor provides a single void, which the collector then pours into two containers: at least 30 mL into Bottle A (primary) and at least 15 mL into Bottle B (split), or collects the specimen in two sequential voids under the same procedure.
  3. The collector checks the specimen’s temperature within four minutes of collection and records it on the CCF, flagging any reading outside the acceptable range.
  4. Both bottles receive tamper-evident seals, applied by the donor or collector depending on site protocol, and the donor initials each seal to confirm they witnessed the sealing.
  5. The collector completes the CCF with specimen ID numbers, date, time, and donor certification, then distributes copies to the required parties: the lab, the collector’s own records, and the employer’s designated representative.
  6. The primary lab tests Bottle A first. Bottle B stays sealed and stored at the first lab.
  7. If Bottle A comes back positive, adulterated, or substituted, and the MRO notifies the donor, the donor’s window to request split testing opens.
  8. Once a valid request arrives, the first laboratory forwards Bottle B, still sealed, to a second HHS-certified laboratory for independent reconfirmation.

Every handoff in this chain gets a CCF entry. A missing signature, an unsealed bottle, or an unrecorded temperature reading can all become grounds to challenge a result later, which is why collectors are trained to document each step as it happens rather than after the fact.

Requesting a split test: the 72-hour rule and how to use it

The right to request split specimen testing belongs to the donor alone, and the clock starts running the moment the MRO delivers notice of a verified positive, adulterated, or substituted result. Under § 40.171, the donor has 72 hours from that notification to make the request.

A few practical points matter here:

  • The request can be made verbally or in writing directly to the MRO, but a written record protects the donor if timing is ever disputed.
  • The MRO logs the date and time of the request, which becomes part of the official record.
  • If the donor misses the window because of a documented serious illness, lack of actual notice, or another circumstance the MRO finds legitimate, the MRO has discretion to still honor a late request.
  • Once a timely request lands, the employer has no discretion: testing must move forward.

Pro Tip: Call or email the MRO’s office directly rather than relying on a supervisor to relay your request. A direct paper trail with a timestamp is the strongest protection if the window is ever questioned.

Who pays and how the timeline works

The regulatory answer on payment is clear and leaves little room for employer discretion. Under § 40.173, once an employee makes a timely request, the employer must ensure the split specimen gets forwarded to a second HHS-certified lab promptly, regardless of who ultimately covers the cost.

The FMCSA’s own guidance reinforces this: if a driver requests split testing but cannot pay immediately, the employer still has to ensure the test proceeds without requiring upfront payment. Employers can recover costs later through company policy or a collective bargaining agreement, but they cannot hold the test hostage to payment.

A few operational realities shape how smoothly this goes:

  • Employers who maintain pre-established accounts with HHS-certified labs avoid the scramble that happens when a split request arrives and nobody knows which lab to call.
  • Every date and time tied to the request and the forwarding decision belongs on the CCF, since gaps here are what fuel later disputes.
  • When no split laboratory is available to test for a specific adulterant, the result is a cancellation, not a stalled test. The MRO reports the failure to reconfirm, notifies both parties, and directs an immediate direct-observed re-collection, which becomes the new result of record.

Delays tend to happen not because the rule is unclear but because nobody at the employer’s end has a ready answer for who to call. A written policy that names the lab and the point of contact in advance removes most of that friction.

The five outcomes: what the MRO does with split lab results

Once the second lab finishes testing Bottle B, the MRO has to classify the outcome into one of five categories under § 40.187, and each one triggers a specific required action.

  • Reconfirmed: Bottle B confirms Bottle A’s result, and the verified positive, adulterated, or substituted finding stands.
  • Failed to reconfirm: Bottle B does not confirm the original finding, so the MRO cancels the test rather than treating it as negative.
  • Adulterated or substituted confirmed: the second lab independently verifies the adulteration or substitution finding.
  • Specimen unavailable for testing: the split cannot be analyzed due to insufficient volume or damage, prompting cancellation and typically a new collection under direct observation.
  • Results inconsistent with the first lab: the MRO may order specimen validity testing or route the sample to a third HHS-certified laboratory for additional analysis.

Split testing follows a defined decision tree under § 40.187, which spells out exactly what the MRO must do in each of these five scenarios, leaving little room for improvisation once a result comes back.

A reconfirmed result stands as the official verified positive on the employee’s record. A failed-to-reconfirm outcome cancels the original test outright rather than converting it to a negative, and depending on the circumstances, the MRO may order an immediate direct-observed re-collection to establish a new result of record.

Illustrated split specimen result outcome paths

What employees and employers should do after a positive primary result

Acting fast and documenting everything protects both sides once a primary result comes back positive.

  1. Employees: request split testing in writing within the 72-hour window and keep a copy of every message sent to the MRO.
  2. Employees: ask the MRO which second lab received Bottle B and request the tracking or specimen ID number.
  3. Employers: confirm the forwarding date on the CCF and verify the receiving lab holds current HHS certification.
  4. Employers: never condition forwarding on the employee’s ability to pay upfront, per § 40.173.
  5. Both parties: watch for red flags like broken tamper-evident seals, missing CCF signatures, or unexplained multi-day gaps between steps.

Pro Tip: Keep a simple dated log of every call, email, and form you send during a split specimen dispute. If the case ever reaches arbitration or a workers’ compensation proceeding, that log often matters more than memory.

How we support compliant split-specimen workflows

We work with laboratories that meet SAMHSA, CLIA, CAP, and ISO standards, which matters when a split specimen needs to move to a second certified facility without delay. Our team can help employers line up mail-in confirmation kits and certified lab contacts ahead of time, so a split request does not turn into a logistics scramble. We do not process the legal dispute itself; our role is making sure the testing side of the process runs on schedule.

The gap between the regulation and the real workplace

Most split specimen disputes we see trace back to timing and paperwork, not bad faith. A supervisor forgets to relay a verbal request, a CCF entry gets left blank, or an employer assumes the clock paused because nobody confirmed receipt. None of that is malicious, but all of it can turn a straightforward reconfirmation into a weeks-long argument. The fix is almost always the same: write it down, send it in writing, and act inside the window rather than after it closes.

— Alan

Where CountryWideTesting.com fits into your testing program

Countrywidetesting

If you are an employer trying to keep a drug testing program compliant, or an individual who wants a second opinion processed by a certified lab, our lab testing services connect you with HHS-capable labs built for exactly this kind of work. We also carry mail-in confirmation kits that can support a confirmation workflow when you need results routed through a certified facility rather than handled on-site. None of this replaces your legal right to request split testing through your MRO. It is simply a practical way to make sure the logistics on your end keep pace with the clock the regulation sets. For employers managing workplace injury claims tied to a testing dispute, outside resources like a workers’ comp benefit estimator can help clarify what is at stake procedurally. Browse our lab test collection to see current options.

FAQ

What does a split specimen drug test mean?

A split specimen drug test divides a single urine sample into two sealed bottles, Bottle A and Bottle B, collected at the same time. Bottle A gets tested first, and Bottle B stays sealed in case the donor requests independent reconfirmation after a positive, adulterated, or substituted result under § 40.171.

Can synthetic urine be detected in a lab?

HHS-certified laboratories run specimen validity tests that check for the natural markers found in human urine, and samples lacking them get flagged as substituted rather than analyzed as a normal result. The SAMHSA Urine Specimen Collection Handbook outlines these validity checks as a standard part of certified lab procedure.

What drug test is hardest to pass?

Difficulty depends on the detection window and testing method rather than any single test being universally hardest. Hair follicle testing generally covers the longest detection window of the common methods, while lab-based urine testing under DOT protocols adds validity and adulteration checks that make attempts to defeat the test harder to succeed at.

What is a 2 panel drug test?

A 2 panel drug test screens for two specific substances, typically selected based on workplace risk or regulatory requirement, rather than the broader multi-panel tests used in many federal programs. It follows the same basic collection and confirmation principles as other urine-based screens, just with a narrower scope.

Sources

Back to Learning Center